Immune-related adverse effects of checkpoint immunotherapy and implications for the treatment of patients with cancer and autoimmune diseases
During the past decade, there has been a revolution in cancer therapeutics by the emergence of antibody-based immunotherapies that modulate immune responses against tumors. These therapies have offered treatment options to patients who are no longer responding to classic anti-cancer therapies. By bl...
Saved in:
Main Author: | Ibis B. |
---|---|
Other Authors: | Mahidol University |
Format: | Review |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/87700 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Transcriptional regulation of cancer immune checkpoints: Emerging strategies for immunotherapy
by: Simran Venkatraman, et al.
Published: (2020) -
Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohort
by: Panchawagh S.
Published: (2023) -
Immunotherapy in autoimmune diseases
by: Fong, K.Y.
Published: (2014) -
Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
by: Ng K.Y.Y., et al.
Published: (2022) -
Pharmacogenomic prediction of immune-related adverse events from immune checkpoint inhibitors among Asian patients
by: Huang, Yiqing, et al.
Published: (2022)